SEARCH

SEARCH BY CITATION

References

  • APPERLEY, E., HUMPHREY, P.P.A. & LEVY, G.P. (1976). Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br. J. Pharmacol., 58, 211221.
  • APRIGLIANO, O. & HERMSMEYER, K. (1976). In vitro denervation of the portal vein and caudal artery of the rat. J. Pharmacol. Exp. Ther., 198, 568577.
  • BLACK, J.L., FRENCH, R.J. & MYLECHARANE, E.J. (1981). Receptors mechanism for 5-hydroxytryptamine in rabbit arteries. Br. J. Pharmacol., 74, 619626.
  • BLACKSHEAR, J.L., ORLANDI, C. & HOLLENBERG, N.K. (1986). Serotonin and the renal blood supply: Role of prostaglandins and the 5-HT2 receptor. Kidney Int., 30, 304310.
  • BRADLEY, P.B., ENGEL, G., FENIUK, W., FOZARD, J.R., HUMPHREY, P.P.A., MIDDLEMISS, D.N., MYLECHARANE, E.J., RICHARDSON, B.P. & SAXENA, P.R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology, 25, 563576.
  • CALDICOTT, W.H.H., HOLLENBERG, N.K. & ABRAMS, H.L. (1970). Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest. Radiol., 5, 539547.
  • CAMBRIDGE, D., WHITING, M.V. & BUTTERFIELD, L.J. (1991). 5-Carboxamidotryptamine induced renal vasoconstriction in the dog. In Serotonin, Molecular Biology, Receptors and Function. ed. Fozard, J.R. & Saxena, P.R. Basel: Birkhauser, (in press).
  • CHARLTON, K.G., BOND, R.A. & CLARKE, D.E. (1986). An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Naunyn-Schmiedebergs Arch. Pharmacol., 332, 815.
  • DE LEAN, A., MUNSON, P.J. & RODBARD, R. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am. J. Physiol., 235, 97102.
  • DEN BOER, M.O., VILLALÓN, C.M., HEILIGERS, J.P.C., HUMPHREY, P.P.A. & SAXENA, P.R. (1991). Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br. J. Pharmacol., 102, 323330.
  • FENIUK, W. (1984). An analysis of 5-hydroxytryptamine receptors mediating contraction of isolated smooth muscle. Neuropharmacology, 23, 14671472.
  • FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1985). A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br. J. Pharmacol., 86, 697704.
  • FOZARD, J.R. (1984). MDL 72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedebergs Arch. Pharmacol., 326, 3644.
  • HOFFMAN, B.B. & LEFKOWITZ, R.J. (1990). Adrenergic receptor antagonists. In The Pharmacological Basis of Therapeutics. ed. Gilman, Goodman A., Rall, T.W., Nies, A.S. & Taylor, P. pp. 221243. New York: Pergamon Press.
  • HOYER, D. (1989). 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In The Peripheral Actions of 5-hydroxytryptamine. ed. Fozard, J.R. pp. 7399. Oxford: Oxford University Press.
  • HOYER, D., ENGEL, G. & KALKMAN, H.O. (1985). Molecular Pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur. J. Pharmacol., 118, 1323.
  • HUMPHREY, P.P.A., FENIUK, W., PERREN, M.J., CONNOR, H.E., OXFORD, A.W., COATES, I.H. & BUTINA, D. (1988). GR 43175, a selective agonist for 5-HT1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 11231132.
  • ISMAIEL, A.M., TITELER, M., MILLER, K.J., SMITHS, T.S. & GLENNON, R.A. (1990). 5-HT1 and 5-HT2 binding profiles of the serotonergic agents α-methyl-serotonin and 2-methyl-serotonin. J. Med. Chem., 33, 755758.
  • KENAKIN, T.P. (1987). Pharmacologic Analysis of Drug Receptor Interaction. p. 213. New York: Raven Press.
  • MARTIN, G.R. & MacLENNAN, S.J. (1990). Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmiedebergs Arch. Pharmacol., 342, 111119.
  • McCUBBIN, J.W., KANEKO, Y. & PAGE, I.H. (1962). Inhibition of neurogenic vasoconstriction by serotonin. Vasodilator action of serotonin. Circ. Res., 11, 7483.
  • McGRATH, M.A. (1977). 5-Hydroxytryptamine and neurotransmitter release in canine blood vessels, inhibition by low and augmentation by high concentrations. Circ. Res., 41, 428435.
  • MIDDLEMISS, D.N. & FOZARD, J.R. (1983). 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur. J. Pharmacol., 90, 151153.
  • PARSONS, A.A., WHALLEY, E.T., FENIUK, W., CONNOR, H.E. & HUMPHREY, P.P.A. (1989). 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br. J. Pharmacol., 96, 434440.
  • PEROUTKA, S.J. & McCARTHY, B.G. (1989). Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur. J. Pharmacol., 163, 133136.
  • RICHARDSON, B.P. & HOYER, D. (1990). Selective agonists and antagonists at 5-hydroxytryptamine receptor subtypes. In Serotonin: from Cell Biology to Pharmacology and Therapeutics. ed. Paoletti, R., Vanhoutte, P.M., Brunello, N. & Maggi, F.M. pp. 265276. Dordrecht: Kluwer Academic Publishers.
  • SAHIN-ERDEMLI, I., HOYER, D., STOLL, A., SEILER, M.P. & SCHOEFFTER, P. (1991). 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction in guinea-pig isolated iliac artery. Br. J. Pharmacol., 102, 386390.
  • SAXENA, P.R., BOM, A.H. & VERDOUW, P.D. (1989). Characterization of 5-hydroxytryptamine receptors in the cranial vasculature. Cephalalgia., 9 (suppl. 9), 1522.
  • SAXENA, P.R., FORSYTH, R.P., JOHNSTON, B.M. & DE WERK, A. (1978). Regional and systemic haemodynamic changes evoked by 5-hydroxytryptamine in awake and anaesthetized rabbits. Eur. J. Pharmacol., 50, 6168.
  • SAXENA, P.R. & VILLALÓN, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15 (suppl. 7), S17S34.
  • SCHOEFFTER, P. & HOYER, D. (1989). How selective is GR43175? Interactions with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn-Schmiedebergs Arch. Pharmacol., 340, 135138.
  • SHOJI, T., TAMAKI, T., FUKUI, K., IWAO, H. & ABE, Y. (1989). Renal haemodynamic responses to 5-hydroxytryptamine (5-HT): involvement of the 5-HT receptor subtypes in the canine kidney. Eur. J. Pharmacol., 171, 219228.
  • SUMNER, M.J. & HUMPHREY, P.P.A. (1989). 5-HT1D binding sites in porcine brain can be subdivided by GR43175. Br. J. Pharmacol., 98, 2931.
  • VAN HEUVEN-NOLSEN, D., KLASEN, TYSSE T.H.M., LUO, Q. & SAXENA, P.R. (1990). 5-HT1-like receptors mediate contractions in the rabbit saphenous vein. Eur. J. Pharmacol., 191, 375382.
  • VERBEUREN, T.J., LAUBIE, M., MENNECIER, P., PROST, J.-F. & ROCHAT, C. (1990). Does 5-HT1A receptor activation cause renal vasodilation. Eur. J. Pharmacol., 183, 666.
  • VYDEN, J.K., LENT, D., NAGASAWA, K., CARVAHLO, M., SERRUYA, A. & CORDAY, E. (1974). The effects of serotonin on regional haemodynamics in the vascular system. J. Clin. Pharmacol., 14, 434441.
  • WRIGHT, C.E. & ANGUS, J.A. (1987). Diverse vascular responses to serotonin in the conscious rabbit: effects of serotonin antagonists on renal artery spasm. J. Cardiovasc. Pharmacol., 10, 415423.
  • WRIGHT, C.E. & ANGUS, J.A. (1989). 5-Carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: Evidence for 5-HT release from platelets. J. Cardiovasc. Pharmacol., 13, 557564.